BUY Cohance Lifesciences Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)25 Mar 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·13 Feb · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cohance Lifesciences
- BUY — Arun Kumar Mantri21 Oct 2026 · ~2 weeks · target ₹495 · SL hit
- BUY — Investec India21 Oct 2026 · ~1 year · target ₹560 · Active
- BUY — IDBI Capital7 Oct 2026 · ~2 weeks · target ₹490 · SL hit
- BUY — Amit Shreeram Goel21 Aug 2026 · ~2 weeks · target ₹533 · Expired
- BUY — Mehul Kothari, Anand Rathi20 Aug 2026 · ~3 months · target ₹550 · SL hit
More from ICICI Securities
- BUY CIE Automotive India23 Oct 2026 · ~1 year · target ₹475 · Active
- BUY SAGILITY23 Oct 2026 · ~1 year · target ₹55 · Active
- BUY CREDITACCESS GRAMEEN23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Havells India23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Balkrishna Industries22 Oct 2026 · ~1 year · target ₹2,675 · Active

